AUSL della Romagna-Ospedale Santa Maria delle Croci Ravenna

Research site

Italy 5 Viale Vincenzo Randi, 48121 Ravenna, Italy

1 trial recruiting
Squamous cell carcinoma of lung · Non-small cell lung cancer · Non-small cell lung cancer stage IV
Adult patients

About Specializations

AUSL della Romagna-Ospedale Santa Maria delle Croci Ravenna in Ravenna, Italy specialises in clinical trials of conditions such as Squamous cell carcinoma of lung, Non-small cell lung cancer, Non-small cell lung cancer stage IV, Non-small cell lung cancer stage IIIB, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

5 Viale Vincenzo Randi48121 RavennaItaly

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 8

More sites in Ravenna Italy

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Squamous cell carcinoma of lung+4

Recruiting

A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

InvestigationalNo placebo

A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Sigvotatug vedotin
Sponsor:Pfizer Inc.

Contact Research Centre

Chronic lymphocytic leukaemia+2

Not yet recruiting

Clinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma

Registered drugNo placebo

Clinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:Grifols Therapeutics LLC

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites